Sue Currie
Directeur des opérations chez Virion Therapeutics LLC
Profil
Sue Currie is currently the Chief Operating Officer at Virion Therapeutics LLC since 2021.
Previously, she worked as the Vice President & Head-Medical Affairs at Nektar Therapeutics.
Dr. Currie completed her undergraduate degree at the University of Saskatchewan, her graduate degree at the University of Phoenix, and her doctorate at the University of San Francisco.
Postes actifs de Sue Currie
| Sociétés | Poste | Début |
|---|---|---|
Virion Therapeutics LLC
 Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Directeur des opérations | 22/11/2021 |
Anciens postes connus de Sue Currie
| Sociétés | Poste | Fin |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Formation de Sue Currie
| University of Saskatchewan | Undergraduate Degree |
| University of Phoenix | Graduate Degree |
| University of San Francisco | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| Entreprise privées | 1 |
|---|---|
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Health Technology |
